操作建议
卡地纳健康当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在药品行业排名32/159位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价214.44。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
卡地纳健康简介
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
公司代码CAH
公司卡地纳健康
CEOWeitzman (Deborah L)
网址https://www.cardinalhealth.com/en.html
常见问题
卡地纳健康(CAH)的当前股价是 199.520。
现在卡地纳健康(CAH)的股票是买入、持有还是卖出?
根据分析师评级,卡地纳健康(CAH)的总体评级为买入,目标价格为214.444。
卡地纳健康(CAH)股票的每股收益(EPS TTM)是多少
卡地纳健康(CAH)股票的每股收益(EPS TTM)是6.656。